Gene: SCOC
Official Full Name: short coiled-coil proteinprovided by HGNC
Gene Summary: This gene encodes a short coiled-coiled domain-containing protein that localizes to the Golgi apparatus. The encoded protein interacts with ADP-ribosylation factor-like proteins. Pseudogenes of this gene are found on chromosomes 1 and 14. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14309 | SCOC Knockout cell line (HeLa) | Human | SCOC | 1:3~1:6 | Negative | Online Inquiry |
KO14310 | SCOC Knockout cell line (HCT 116) | Human | SCOC | 1:2~1:4 | Negative | Online Inquiry |
KO14311 | SCOC Knockout cell line (HEK293) | Human | SCOC | 1:3~1:6 | Negative | Online Inquiry |
KO14312 | SCOC Knockout cell line (A549) | Human | SCOC | 1:3~1:4 | Negative | Online Inquiry |
SCOC Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study and functional characterization of the Stem Cell Oligodendrocyte Cell (SCOC) gene. Utilizing advanced CRISPR-Cas9 genome editing techniques, these cell lines enable researchers to achieve precise deletions of the SCOC gene, thereby creating a platform for the investigation of its biological roles and implications in various cellular processes.
The primary functionality of the SCOC Gene Knockout Cell Lines lies in their ability to elucidate the effects of the absence of the SCOC gene on cellular behavior and differentiation pathways. By comparing the knockout lines to their wild-type counterparts, scientists can assess changes in signaling pathways, morphology, gene expression profiles, and overall cell function. This capability is vital for understanding the role of SCOC in neurodevelopment, myelination, and potentially in neurodegenerative diseases.
The scientific importance of these cell lines extends to both basic research and clinical applications. In research settings, they serve as invaluable tools for dissecting gene function, validating targets for therapeutic interventions, and developing models for disease conditions. In clinical applications, insights garnered from these studies could lead to new strategies for the treatment of disorders related to oligodendrocyte function, such as multiple sclerosis or leukodystrophies.
When compared to alternative models, the SCOC Gene Knockout Cell Lines hold several key advantages. The use of CRISPR-Cas9 not only ensures a high efficiency of gene knockouts but also minimizes off-target effects, resulting in more reliable data. Furthermore, the ability to generate stable knockout cell lines allows for long-term studies and reproducibility of experimental results.
For researchers and clinicians focused on neurobiology, the SCOC Gene Knockout Cell Lines represent a powerful resource for advancing our understanding of oligodendrocyte biology and its implications in health and disease. Our company prides itself on providing quality, well-characterized biological products that empower the scientific community, drawing on years of expertise in cellular engineering to deliver innovative and reliable solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.